Kolumne, ORE

Original-Research: Netfonds AG - von NuWays AG Einstufung von NuWays AG zu Netfonds AG Unternehmen: Netfonds AG ISIN: DE000A1MME74 Anlass der Studie: Update Empfehlung: BUY seit: 09.02.2024 Kursziel: 71.00 Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: Analyst: Frederik Jarchow Favorable trends to materialize in 2024 Netfonds should strongly benefit from several favorable macroeconomic and structural trends in 2024: Strong dollar and equity capital markets close to all-time highs.

09.02.2024 - 09:46:32

Original-Research: Netfonds AG (von NuWays AG): BUY


Original-Research: Netfonds AG - von NuWays AG

Einstufung von NuWays AG zu Netfonds AG

Unternehmen: Netfonds AG
ISIN: DE000A1MME74

Anlass der Studie: Update
Empfehlung: BUY
seit: 09.02.2024
Kursziel: 71.00
Kursziel auf Sicht von: 12 Monaten
Letzte Ratingänderung: 
Analyst: Frederik Jarchow

Favorable trends to materialize in 2024
 
Netfonds should strongly benefit from several favorable macroeconomic and
structural trends in 2024:
 
Strong dollar and equity capital markets close to all-time highs. With c. EUR
23.2bn AuC in FY23e (eNuW), Netfonds topline is obviously correlated to the
overall capital markets development. The recent solid performance of major
indices should result in performance related AuC growth, which in turn
should increase revenues, even without new AuC inflows (which are likely).
As a significant share of overall AuC is invested in funds traded in USD,
the strong USD should further fuel revenues.
 
Inflows into highly profitable wealth management (Hamburger Vermögen).
Wealth management should have shown the strongest growth momentum in FY23
(eNuW: 25% to > EUR 3bn) that is expected to continue. As margins in wealth
management are higher than in wholesale, the overall margins on AuC should
hence grow substantially.
 
Renaissance of money market funds should bode well for NFS Capital.
Netfonds recently set up an own money market fund that faces significant
inflows. Indeed, the money market was the asset class with the highest
inflows in the last quarters, currently experiencing a kind of renaissance
after years of low interest environment.
 
Finfire to fuel consolidation of the insurance broker market. After having
optimized finfire according to the needs of investment advisors, the focus
of the inhouse development teams is now on insurance. Other than the
investment adviser market, the insurance broker market is still highly
fragmented, but on the move. Netfonds should be one of the few major
beneficiaries of the coming consolidation.
 
Enormous cross-selling potential. The development of new, additional
features that should ease the selling and managing of insurance products,
unlocks huge cross-selling potentials, as the already onboarded investment
adviser can additionally offer a wide range of insurance products to its
customers via Netfonds proprietary, 360

finfire platform that remains thecompanyŽs key mid- to long term growth and scalability driver.

Overall, we expect EUR 204.4m gross sales, EUR 43.9m net sales and an EBITDA ofEUR 12.5m for FY24e.

BUY with an unchanged PT of EUR 71.00, based on DCF.

Die vollständige Analyse können Sie hier downloaden:http://www.more-ir.de/d/28849.pdfDie Analyse oder weiterführende Informationen zu dieser können Sie hier downloadenwww.nuways-ag.com/research.

Kontakt für RückfragenDie Analyse oder weiterführende Informationen zu dieser können Sie hier downloadenwww.nuways-ag.com/research.Kontakt für RückfragenNuWays AG - Equity ResearchWeb: www.nuways-ag.comEmail: research@nuways-ag.comLinkedIn: https://www.linkedin.com/company/nuwaysagAdresse: Mittelweg 16-17, 20148 Hamburg, Germany++++++++++Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.++++++++++

-------------------übermittelt durch die EQS Group AG.-------------------

Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatungoder Aufforderung zum Abschluss bestimmter Börsengeschäfte.

°

@ dpa.de

Weitere Meldungen

Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research Gm... Original-Research: Schloss Wachenheim AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to Schloss Wachenheim AG Company Name: Schloss Wachenheim AG ISIN: DE0007229007 Reason for the research: Q3 23/24 results Recommendation: Buy from: 13.05.2024 Target price: EUR22,00 Target price on sight of: 12 months Last rating change: - Analyst: Simon Scholes, CFA First Berlin Equity Research has published a research update on Schloss Wachenheim AG (ISIN: DE0007229007). (Boerse, 13.05.2024 - 11:41) weiterlesen...

Original-Research: LION E-Mobility AG (von NuWays AG): Kaufen Original-Research: LION E-Mobility AG - from NuWays AG Classification of NuWays AG to LION E-Mobility AG Company Name: LION E-Mobility AG ISIN: CH0560888270 Reason for the research: Update Recommendation: Kaufen from: 13.05.2024 Target price: EUR 7.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Christian Sandherr CMD underpins promising mid-term prospects; chg Q1 sales came in at a mere EUR 1.2m with an EBITDA of EUR -2.6m. This is a significant decrease compared to the particularly strong Q4 last year with roughly EUR 26m sales and EUR 1m EBITDA. (Boerse, 13.05.2024 - 09:06) weiterlesen...

Original-Research: MLP SE (von NuWays AG): Kaufen Original-Research: MLP SE - from NuWays AG Classification of NuWays AG to MLP SE Company Name: MLP SE ISIN: DE0006569908 Reason for the research: Update Recommendation: Kaufen from: 13.05.2024 Target price: EUR 12.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Henry Wendisch Q1 preview: performance fees and banking to drive EBIT Topic: MLP's Q1 results are due on Wednesday, May 15th and we expect a solid EBIT expansion driven by a contribution of performance fees (first time since Q4'21) as well as continuous support from the banking business. (Boerse, 13.05.2024 - 09:02) weiterlesen...

Original-Research: Multitude SE (von NuWays AG): Kaufen Original-Research: Multitude SE - from NuWays AG Classification of NuWays AG to Multitude SE Company Name: Multitude SE ISIN: FI4000106299 Reason for the research: Update Recommendation: Kaufen from: 13.05.2024 Last rating change: Analyst: Frederik Jarchow Solid Q1 figures ahead // Multitude to continue on growth path On Thursday, Multitude will report Q1Ž24 figures that should come in solid, but with room for sequential improvements until YE. (Boerse, 13.05.2024 - 09:01) weiterlesen...

Original-Research: Nynomic AG (von Montega AG): Kaufen Original-Research: Nynomic AG - von Montega AG Einstufung von Montega AG zu Nynomic AG Unternehmen: Nynomic AG ISIN: DE000A0MSN11 Anlass der Studie: Update Empfehlung: Kaufen seit: 10.05.2024 Kursziel: 47,00 EUR (zuvor: 48,00 EUR) Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: - Analyst: Miguel Lago Mascato Q1: Solider Jahresauftakt - Steigerung der ausgezeichneten H2/23-Performance & M&A-Newsflow erwartet Nynomic hat Mittwoch Q1-Zahlen veröffentlicht, die eine spürbare Steigerung ggü. (Boerse, 10.05.2024 - 16:16) weiterlesen...

Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH)... Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to MPH Health Care AG Company Name: MPH Health Care AG ISIN: DE000A289V03 Reason for the research: Vorläufige Ergebnisse 2023 Recommendation: Kaufen from: 10.05.2024 Target price: EUR81 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. (Boerse, 10.05.2024 - 12:41) weiterlesen...